Scintigraphic detection of tumour necrosis factor in patients with rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 62, Issue 9, 2003, Pages 825-828

  Barrera, P ^a   Oyen, W J G ^a   Boerman, O C ^a   Van Riel, P L C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; TECHNETIUM 99M; TRACER; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ANTIBODY LABELING; ARTICLE; CIRCULATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DOSE RESPONSE; DRUG HALF LIFE; FEMALE; HUMAN; INFLAMMATION; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MALE; RHEUMATOID ARTHRITIS; SCINTIGRAPHY;

AGED; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; RADIOIMMUNODETECTION; SENSITIVITY AND SPECIFICITY; SYNOVITIS; TECHNETIUM; TISSUE DISTRIBUTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0042386443     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.9.825     Document Type: Article

References (24)

1. Deleuran BW, Chu CQ, Field M, Brennan FM, Mitchell T, Feldmann M, et al. Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha. Arthritis Rheum 1992;35:1170-8.
2. Chu CQ, Field M, Feldmann M, Maini RN. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1125-32.
3. Barrera P, Joosten LA, den Broeder AA, van de Putte LB, van Riel PL, van den Berg WB. Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFα in patients with rheumatoid arthritis. Ann Rheum Dis 2001;60:660-9.
4. Ulfgren AK, Grondal L, Lindblad S, Khademi M, Johnell O, Klareskog L, et al. Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment. Ann Rheum Dis 2000;59:439-47.
5. van der Laken CJ, Boerman OC, Oyen WJ, van de Ven MT, van der Meer JW, Corstens FH. Imaging of infection in rabbits with radioiodinated interleukin-1 (alpha and beta), its receptor antagonist and a chemotactic peptide: a comparative study. Eur J Nucl Med 1998;25:347-52.
6. van der Laken CJ, Boerman OC, Oyen WJ, van de Ven MT, Ven der Meer JW, Corstens FH. The kinetics of radiolabelled interleukin-8 in infection and sterile inflammation. Nucl Med Commun 1998;19:271-81.
7. Chapman PT, Jamar F, Keelan ET, Peters AM, Haskard DO. Use of a radiolabeled monoclonal antibody against E-selectin for imaging of endothelial activation in rheumatoid arthritis. Arthritis Rheum 1996;39:1371-5.
8. Jamar F, Chapman PT, Manicourt DH, Glass DM, Haskard DO, Peters AM. A comparison between 111In-anti-E-selectin mAb and 99mTc-labelled human non-specific immunoglobulin in radionuclide imaging of rheumatoid arthritis. Br J Radiol 1997;70:473-81.
9. Steffens MG, Oosterwijk E, Kranenborg MH, Manders JM, Debruyne FM, Corstens FH, et al. In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations. J Nucl Med 1999;40:829-36.
10. Salfeld J, Kaymakcalan Z, Tracey D, Roberts A, Kamen R. Generation of fully human anti-TNF antibody D2E7 [abstract]. Arthritis Rheum 1998;41(suppl):S57.
11. Santora LC, Krull IS, Grant K. Characterization of recombinant human monoclonal tissue necrosis factor-alpha antibody using cation-exchange HPLC and capillary isoelectric focusing. Anal Biochem 1999;275:98-108.
12. Rau R. Adalimumab (a fully human anti-tumour necrosis factor α monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials. Ann Rheum Dis 2002;61(suppl II):ii70-3.
13. Kempeni J. Update on D2E7: a fully human anti-tumour necrosis factor α monoclonal antibody. Ann Rheum Dis 2000;59(suppl I):i44-5.
14. den Broeder AA, Joosten LA, Saxne T, Heinegard D, Fenner H, Miltenburg AM, et al. Long term anti-tumour necrosis factor α monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation. Ann Rheum Dis 2002;61:311-18.
15. Keystone E, Kavanaugh AF, Sharp J, Hua Y, Teoh L, Fischkoff S, et al. Adalimumab (D2E7), a fully human anti-TNF-α monoclonal antibody, inhibits the progression of structural joint damage in patients with active A despite concomitant methotrexate therapy [abstract]. Arthritis Rheum 2002;46(suppl):S205.
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
17. van der Heijde DM, van 't Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990;49:916-20.
18. Abrams MJ, Juweid M, tenKate CI, Schwartz DA, Hauser MM, Gaul FE, et al. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med 1990;31:2022-8.
19. Hnatowich DJ, Qu T, Chang F, Ley AC, Ladner RC, Rusckowski M. Labeling peptides with technetium-99m using a bifunctional chelator of a N-hydroxysuccinimide ester of mercaptoacetyltriglycine. J Nucl Med 1998;39:56-64.
20. Dams ET, Oyen WJ, Boerman OC, Claessens RA, Wymenga AB, van der Meer JW, et al. Technetium-99m labeled to human immunoglobulin G through the nicotinyl hydrazine derivative: a clinical study. J Nucl Med 1998;39:119-24.
21. Buijs WC, Oyen WJ, Dams ET, Boerman OC, Siegel JA, Claessens RA, et al. Dynamic distribution and dosimetric evaluation of human nonspecific immunoglobulin G labelled with In-111 or Tc-99m. Nucl Med Commun 1998;19:743-51.
22. Oyen WJ, Boerman OC, van der Laken CJ, Claessens RA, van der Meer JW, Corstens FH. The uptake mechanisms of inflammation- and infection-localizing agents. Eur J Nucl Med 1996;23:459-65.
23. van der Laken CJ, Boerman OC, Oyen WJ, van de Ven MT, van der Meer JW, Corstens FH. Scintigraphic detection of infection and inflammation: new developments with special emphasis on receptor interaction. Eur J Nucl Med 1998;25:535-46.
24. Joosten LA, Radstake TR, Lubberts E, van Lent PL, den Bersselaar LA, van Riel PL, et al. IL-18 expression in synovial biopsies of patients with active rheumatoid arthritis is associated with enhanced levels of both IL-1 and TNF [abstract]. Arthritis Rheum 2002;46(suppl):S550.